MADRIGAL PHARMACEUTICALS, INC. (MDGL)

Form 4 sales, Form 144 notices and lockup dates

Sales chart range
Log in to watch MDGL
Latest sale
$6.2M
Sep 11 · Unusual
Form 4 sales
115
On record
Form 144 notices
82
Proposed sales
Next unlock
None
No lockup ahead

Lockups

No lockup on record.

Sales by reason

0
Routine
0
Plan not stated
0
No plan
1
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Timeline

  1. 1 Form 4 saleRoutine
    May 22, 2026 2026

    Sold 5,682 shares at $515.44 ($2.9M)

    Levy Richard S, Director

    10b5-1 planSold 20.5% of holdings ($14.3M position)22,015 shares left1.1x usual sizeFollows a Form 144Filing

  2. 2 Form 144 noticeNotice
    Jun 1, 2026 +10 days

    Filed to sell 1,042 shares ($518k)

    Soergel David, Officer

    10b5-1 planFiling

  3. 3 Form 4 saleRoutine
    Jun 1, 2026 same day

    Sold 1,042 shares at $495.74 ($517k)

    Soergel David, Chief Medical Officer

    10b5-1 planSold 9.4% of holdings ($5.5M position)10,033 shares leftFollows a Form 144Filing

  4. 4 Form 4 saleNo plan
    Jul 20, 2026 +49 days

    Sold 2,500 shares at $547.30 ($1.4M)

    Sibold William John, President and CEO

    No 10b5-1 planSold 1.2% of holdings ($116M position)209,329 shares left1x usual sizeFollows a Form 144Filing

  5. 5 Form 144 noticeNotice
    Jul 20, 2026 same day

    Filed to sell 2,500 shares ($1.4M)

    Sibold William John, Officer and Director

    No 10b5-1 plan1x usual sizeFiling

  6. 6 Form 4 saleNo plan
    Aug 17, 2026 +28 days

    Sold 664 shares at $514.97 ($342k)

    Kelley Shannon T, General Counsel

    No 10b5-1 planSold 5.5% of holdings ($6.3M position)11,474 shares left1.6x usual sizeFiling

  7. 7 Form 144 noticeNotice
    Aug 20, 2026 +3 days

    Filed to sell 664 shares ($337k)

    Kelley Shannon T, Officer

    No 10b5-1 plan1.2x usual sizeFiling

  8. 8 Form 4 saleUnusual
    Sep 11, 2026 +22 days

    Sold 11,583 shares at $538.65 ($6.2M)

    Sibold William John, President and CEO

    10b5-1 planSold 5.5% of holdings ($113M position)197,746 shares left4.7x usual sizeFiling

Every transaction

Loading transactions…

Sales, notices and lockups (197)

Export watchlist as CSV
Lockups, Form 144 notices and Form 4 sales for MDGL
Source
Sep 11, 2026Sep 11, 2026Sibold William JohnPresident and CEOForm 4 sale11,583$6.2M5.5%UnusualSEC
Aug 20, 2026Aug 20, 2026Kelley Shannon TOfficerForm 144 notice664$337kNoticeSEC
Aug 17, 2026Aug 20, 2026Kelley Shannon TGeneral CounselForm 4 sale664$342k5.5%No planSEC
Jul 20, 2026Jul 20, 2026Sibold William JohnOfficer and DirectorForm 144 notice2,500$1.4MNoticeSEC
Jul 20, 2026Jul 20, 2026Sibold William JohnPresident and CEOForm 4 sale2,500$1.4M1.2%No planSEC
Jun 1, 2026Jun 1, 2026Soergel DavidChief Medical OfficerForm 4 sale1,042$517k9.4%RoutineSEC
Jun 1, 2026Jun 1, 2026Soergel DavidOfficerForm 144 notice1,042$518kNoticeSEC
May 22, 2026May 22, 2026Levy Richard SDirectorForm 4 sale5,682$2.9M20.5%RoutineSEC
May 22, 2026May 22, 2026Levy Richard SDirectorForm 144 notice5,682$2.9MNoticeSEC
May 18, 2026May 18, 2026Soergel DavidOfficerForm 144 notice844$442kNoticeSEC
May 18, 2026May 18, 2026Soergel DavidChief Medical OfficerForm 4 sale844$435k7.1%No planSEC
Mar 6, 2026Mar 6, 2026Dier MardiOfficerForm 144 notice646$284kNoticeSEC
Mar 6, 2026Mar 6, 2026Sibold William JohnOfficer and DirectorForm 144 notice1,663$731kNoticeSEC
Mar 6, 2026Mar 6, 2026Kelley Shannon TOfficerForm 144 notice360$158kNoticeSEC
Mar 6, 2026Mar 6, 2026Huntsman CaroleOfficerForm 144 notice419$184kNoticeSEC
Mar 6, 2026Mar 6, 2026Taub RebeccaDirectorForm 144 notice491$216kNoticeSEC
Mar 6, 2026Mar 6, 2026Dier MardiOfficerForm 144 notice1,336$587kNoticeSEC
Mar 6, 2026Mar 6, 2026Dier MardiEVP and CFOForm 4 sale1,982$854k13.7%RoutineSEC
Mar 6, 2026Mar 6, 2026Sibold William JohnPresident and CEOForm 4 sale1,663$718k1.0%No planSEC
Mar 6, 2026Mar 6, 2026Kelley Shannon TGeneral CounselForm 4 sale360$155k2.9%No planSEC
Mar 6, 2026Mar 6, 2026Huntsman CaroleChief Commercial OfficerForm 4 sale419$181k3.2%No planSEC
Mar 6, 2026Mar 6, 2026Taub RebeccaDirectorForm 4 sale491$212k0.1%No planSEC
Mar 2, 2026Mar 2, 2026Dier MardiOfficerForm 144 notice1,183$511kNoticeSEC
Mar 2, 2026Mar 2, 2026Dier MardiEVP and CFOForm 4 sale1,183$505k11.3%No planSEC
Jan 26, 2026Jan 26, 2026Huntsman CaroleOfficerForm 144 notice340$163kNoticeSEC
Jan 26, 2026Jan 26, 2026Sibold William JohnOfficer and DirectorForm 144 notice1,577$758kNoticeSEC
Jan 26, 2026Jan 26, 2026Taub RebeccaDirectorForm 144 notice647$311kNoticeSEC
Jan 26, 2026Jan 26, 2026Huntsman CaroleOfficerForm 144 notice570$274kNoticeSEC
Jan 26, 2026Jan 26, 2026Huntsman CaroleChief Commercial OfficerForm 4 sale910$449k9.1%RoutineSEC
Jan 26, 2026Jan 26, 2026Sibold William JohnPresident and CEOForm 4 sale1,577$777k1.1%No planSEC
Jan 26, 2026Jan 26, 2026Taub RebeccaDirectorForm 4 sale647$319k0.1%No planSEC
Jan 20, 2026Jan 20, 2026Kelley Shannon TOfficerForm 144 notice263$132kNoticeSEC
Jan 20, 2026Jan 20, 2026Taub RebeccaDirectorForm 144 notice2,238$1.1MNoticeSEC
Jan 20, 2026Jan 20, 2026Kelley Shannon TOfficerForm 144 notice429$215kNoticeSEC
Jan 20, 2026Jan 20, 2026Kelley Shannon TGeneral CounselForm 4 sale692$344k7.5%RoutineSEC
Jan 20, 2026Jan 20, 2026Taub RebeccaDirectorForm 4 sale2,238$1.1M0.5%No planSEC
Jan 9, 2026Jan 13, 2026Friedman Paul ADirectorForm 4 sale280$154k0.1%RoutineSEC
Jan 9, 2026Jan 13, 2026Friedman Paul ADirectorForm 4 sale24,520$12.8M11.6%RoutineSEC
Jan 9, 2026Jan 13, 2026Taub RebeccaDirectorForm 4 sale240$132k0.1%RoutineSEC
Jan 9, 2026Jan 13, 2026Taub RebeccaDirectorForm 4 sale18,410$9.6M3.9%RoutineSEC
Jan 9, 2026Jan 9, 2026Taub RebeccaDirectorForm 144 notice18,650$10.4MNoticeSEC
Dec 10, 2025Dec 12, 2025Friedman Paul ADirectorForm 4 sale24,800$13.7M11.7%RoutineSEC
Dec 10, 2025Dec 12, 2025Taub RebeccaDirectorForm 4 sale18,650$10.3M3.9%UnusualSEC
Dec 10, 2025Dec 10, 2025Friedman Paul ADirectorForm 144 notice49,600$27.5MNoticeSEC
Dec 10, 2025Dec 10, 2025Taub RebeccaDirectorForm 144 notice18,650$10.3MNoticeSEC
Dec 4, 2025Dec 4, 2025Sibold William JohnOfficer and DirectorForm 144 notice2,400$1.4MNoticeSEC
Dec 4, 2025Dec 4, 2025Sibold William JohnPresident and CEOForm 4 sale2,400$1.4M1.6%No planSEC
Dec 2, 2025Dec 3, 2025Dier MardiEVP and CFOForm 4 sale4,173$2.4M28.6%RoutineSEC
Dec 2, 2025Dec 2, 2025Dier MardiOfficerForm 144 notice4,173$2.4MNoticeSEC
Nov 21, 2025Nov 21, 2025Huntsman CaroleOfficerForm 144 notice1,958$1.1MNoticeSEC
Nov 21, 2025Nov 21, 2025Huntsman CaroleChief Commercial OfficerForm 4 sale1,958$1.1M16.3%RoutineSEC
Nov 13, 2025Nov 14, 2025Levy Richard SDirectorForm 4 sale8,500$4.4M28.6%RoutineSEC
Nov 13, 2025Nov 13, 2025Levy Richard SDirectorForm 144 notice8,500$4.5MNoticeSEC
Nov 5, 2025Nov 7, 2025Bate KennethDirectorForm 4 sale16,575$8M86.3%UnusualSEC
Nov 5, 2025Nov 5, 2025Bate KennethDirectorForm 144 notice16,575$8MNoticeSEC
Sep 9, 2025Sep 9, 2025Sibold William JohnOfficer and DirectorForm 144 notice7,279$3.3MNoticeSEC
Sep 9, 2025Sep 9, 2025Sibold William JohnPresident and CEOForm 4 sale7,279$3.2M6.6%No planSEC
Aug 29, 2025Aug 29, 2025Craves Fred BFormer DirectorForm 144 notice2,900$1.3MNoticeSEC
Aug 21, 2025Aug 21, 2025Sibold William JohnPresident and CEOForm 4 sale7,616$3M6.5%RoutineSEC
Aug 21, 2025Aug 21, 2025Sibold William JohnDirector, OfficerForm 144 notice7,616$3MNoticeSEC
Aug 20, 2025Aug 20, 2025Craves Fred BFormer DirectorForm 144 notice1,000$390kNoticeSEC
Aug 18, 2025Aug 18, 2025Kelley Shannon TOfficerForm 144 notice1,304$482kNoticeSEC
Aug 18, 2025Aug 18, 2025Kelley Shannon TGeneral CounselForm 4 sale1,304$480k12.4%RoutineSEC
Aug 18, 2025Aug 18, 2025Craves Fred BFormer DirectorForm 144 notice2,000$764kNoticeSEC
Aug 15, 2025Aug 15, 2025Craves Fred BFormer DirectorForm 144 notice4,100$1.5MNoticeSEC
Aug 15, 2025Aug 15, 2025Bate KennethDirectorForm 4 sale10,000$3.7M79.2%UnusualSEC
Aug 15, 2025Aug 15, 2025Bate KennethDirectorForm 144 notice10,000$3.7MNoticeSEC
Aug 13, 2025Aug 13, 2025Friedman Paul ADirectorForm 4 sale129,172$47.8M40.8%UnusualSEC
Aug 13, 2025Aug 13, 2025Friedman Paul ADirectorForm 144 notice129,172$46.4MNoticeSEC
Aug 12, 2025Aug 13, 2025Taub RebeccaDirectorForm 4 sale46,463$16.5M9.2%UnusualSEC
Aug 12, 2025Aug 13, 2025Friedman Paul ADirectorForm 4 sale46,808$16.6M20.0%RoutineSEC
Aug 12, 2025Aug 12, 2025Taub RebeccaDirectorForm 144 notice43,263$15.1MNoticeSEC
Aug 12, 2025Aug 12, 2025Friedman Paul ADirectorForm 144 notice43,605$15.2MNoticeSEC
Aug 11, 2025Aug 11, 2025Friedman Paul ADirectorForm 144 notice3,203$1.1MNoticeSEC
Aug 11, 2025Aug 11, 2025Taub RebeccaDirectorForm 144 notice3,200$1.1MNoticeSEC
Jul 18, 2025Jul 22, 2025Taub RebeccaDirectorForm 4 sale1,000$350k0.2%RoutineSEC
Jul 18, 2025Jul 22, 2025Friedman Paul ADirectorForm 4 sale1,400$490k0.7%RoutineSEC
Jul 18, 2025Jul 18, 2025Friedman Paul ADirectorForm 144 notice1,400$488kNoticeSEC
Jul 18, 2025Jul 18, 2025Taub RebeccaDirector, OfficerForm 144 notice1,000$349kNoticeSEC
Jul 17, 2025Jul 18, 2025Friedman Paul ADirectorForm 4 sale28,876$10.2M13.4%RoutineSEC
Jul 17, 2025Jul 18, 2025Taub RebeccaDirectorForm 4 sale29,101$10.3M5.9%UnusualSEC
Jul 17, 2025Jul 17, 2025Taub RebeccaDirector, OfficerForm 144 notice2,657$917kNoticeSEC
Jul 17, 2025Jul 17, 2025Friedman Paul ADirectorForm 144 notice2,700$931kNoticeSEC
Jul 16, 2025Jul 16, 2025Friedman Paul ADirectorForm 144 notice26,176$8.1MNoticeSEC
Jul 16, 2025Jul 16, 2025Taub RebeccaDirector, OfficerForm 144 notice26,444$8.2MNoticeSEC
Mar 13, 2025Mar 14, 2025Craves Fred BDirectorForm 4 sale15,470$5.1M4.2%UnusualSEC
Mar 13, 2025Mar 13, 2025Craves Fred BDirectorForm 144 notice7,742$2.5MNoticeSEC
Mar 12, 2025Mar 12, 2025Craves Fred BDirectorForm 144 notice7,428$2.5MNoticeSEC
Mar 10, 2025Mar 12, 2025Dier MardiSVP and CFOForm 4 sale258$83k2.4%RoutineSEC
Mar 5, 2025Mar 7, 2025Waltermire Robert E.Senior VP, Chief Pharma Dev.Form 4 sale14,113$4.8M79.1%UnusualSEC
Mar 5, 2025Mar 5, 2025Waltermire Robert E.OfficerForm 144 notice14,113$4.8MNoticeSEC
Mar 3, 2025Mar 5, 2025Kelley Shannon TGeneral CounselForm 4 sale415$139k5.4%RoutineSEC
Mar 3, 2025Mar 5, 2025Dier MardiSVP and CFOForm 4 sale1,961$637k22.1%RoutineSEC
Mar 3, 2025Mar 5, 2025Huntsman CaroleChief Commercial OfficerForm 4 sale1,834$598k17.6%RoutineSEC
Mar 3, 2025Mar 3, 2025Dier MardiOfficerForm 144 notice2,219$718kNoticeSEC
Mar 3, 2025Mar 3, 2025Kelley Shannon TOfficerForm 144 notice415$142kNoticeSEC
Mar 3, 2025Mar 3, 2025Huntsman CaroleOfficerForm 144 notice1,834$626kNoticeSEC
Feb 28, 2025Mar 4, 2025Waltermire Robert E.Senior VP, Chief Pharma Dev.Form 4 sale1,227$418k24.8%No planSEC
Feb 28, 2025Feb 28, 2025Waltermire Robert E.OfficerForm 144 notice1,227$418kNoticeSEC
Feb 27, 2025Feb 28, 2025Daly James MDirectorForm 4 sale15,470$5.4M89.0%UnusualSEC
Feb 27, 2025Feb 28, 2025Bate KennethDirectorForm 4 sale20,000$7.1M91.3%UnusualSEC
Feb 27, 2025Feb 27, 2025Daly James MDirectorForm 144 notice15,470$5.4MNoticeSEC
Feb 27, 2025Feb 27, 2025Bate KennethDirectorForm 144 notice20,000$7.1MNoticeSEC
Jan 24, 2025Jan 27, 2025Huntsman CaroleChief Commercial OfficerForm 4 sale347$116k3.2%No planSEC
Jan 24, 2025Jan 27, 2025Sibold William JohnPresident and CEOForm 4 sale1,584$531k2.8%No planSEC
Jan 24, 2025Jan 27, 2025Taub RebeccaPres., R&D, and CMOForm 4 sale648$217k0.1%No planSEC
Jan 24, 2025Jan 27, 2025Waltermire Robert E.Senior VP, Chief Pharma Dev.Form 4 sale103$35k2.0%No planSEC
Jan 24, 2025Jan 24, 2025Taub RebeccaOfficer, DirectorForm 144 notice648$220kNoticeSEC
Jan 24, 2025Jan 24, 2025Huntsman CaroleOfficerForm 144 notice347$118kNoticeSEC
Jan 24, 2025Jan 24, 2025Sibold William JohnOfficer, DirectorForm 144 notice1,584$539kNoticeSEC
Jan 24, 2025Jan 24, 2025Waltermire Robert E.OfficerForm 144 notice103$35kNoticeSEC
Jan 17, 2025Jan 17, 2025Taub RebeccaOfficer, DirectorForm 144 notice1,689$461kNoticeSEC
Jan 17, 2025Jan 17, 2025Kelley Shannon TOfficerForm 144 notice277$76kNoticeSEC
Jan 17, 2025Jan 17, 2025Waltermire Robert E.OfficerForm 144 notice442$121kNoticeSEC
Jan 17, 2025Jan 17, 2025Kelley Shannon TGeneral CounselForm 4 sale277$76k3.5%No planSEC
Jan 17, 2025Jan 17, 2025Waltermire Robert E.Senior VP, Chief Pharma Dev.Form 4 sale442$121k8.0%No planSEC
Jan 17, 2025Jan 17, 2025Taub RebeccaPres., R&D, and CMOForm 4 sale1,689$462k0.4%No planSEC
Dec 3, 2024Dec 5, 2024Craves Fred BDirectorForm 4 sale3,600$1.1M24.7%No planSEC
Nov 25, 2024Nov 27, 2024Craves Fred BDirectorForm 4 sale3,400$1.2M18.9%No planSEC
Nov 25, 2024Nov 25, 2024Craves Fred BDirectorForm 144 notice10,000$3.2MNoticeSEC
Nov 21, 2024Nov 22, 2024Huntsman CaroleChief Commercial OfficerForm 4 sale688$218k6.0%No planSEC
Nov 21, 2024Nov 21, 2024Huntsman CaroleOfficerForm 144 notice688$218kNoticeSEC
Nov 7, 2024Nov 8, 2024Levy Richard SDirectorForm 4 sale5,000$1.8M31.2%RoutineSEC
Nov 7, 2024Nov 7, 2024Levy Richard SDirectorForm 144 notice5,000$1.7MNoticeSEC
Nov 1, 2024Nov 5, 2024Levy Richard SDirectorForm 4 sale5,000$1.5M31.2%RoutineSEC
Nov 1, 2024Nov 1, 2024Levy Richard SDirectorForm 144 notice5,000$1.3MNoticeSEC
Sep 10, 2024Sep 10, 2024Sibold William JohnOfficer, DirectorForm 144 notice6,363$1.6MNoticeSEC
Sep 9, 2024Sep 11, 2024Sibold William JohnPresident and CEOForm 4 sale6,363$1.6M10.2%No planSEC
Jun 14, 2024Jun 18, 2024Waltermire Robert E.Senior VP, Chief Pharma Dev.Form 4 sale1,900$532k25.7%UnusualSEC
Jun 14, 2024Jun 14, 2024Waltermire Robert E.OfficerForm 144 notice1,900$532kNoticeSEC
Jun 14, 2024Jun 14, 2024Lynch Brian JosephOfficerForm 144 notice17,311$4.7MNoticeSEC
Jun 13, 2024Jun 13, 2024Lynch Brian JosephOfficerForm 144 notice35,560$10.1MNoticeSEC
Jun 12, 2024Jun 14, 2024Waltermire Robert E.Senior VP, Chief Pharma Dev.Form 4 sale2,000$570k26.7%UnusualSEC
Jun 12, 2024Jun 12, 2024Waltermire Robert E.OfficerForm 144 notice6,000$1.7MNoticeSEC
Jun 11, 2024Jun 11, 2024Lynch Brian JosephOfficerForm 144 notice9,702$2.8MNoticeSEC
Jun 6, 2024Jun 6, 2024Lynch Brian JosephOfficerForm 144 notice21,030$5MNoticeSEC
May 21, 2024May 23, 2024Waltermire Robert E.Senior VP, Chief Pharma Dev.Form 4 sale1,036$240k15.9%No planSEC
May 14, 2024May 16, 2024Craves Fred BDirectorForm 4 sale22,489$4.8M5.2%RoutineSEC
May 14, 2024May 14, 2024Craves Fred BDirector, 10% StockholderForm 144 notice22,489$4.8MNoticeSEC
Apr 8, 2024Apr 10, 2024Taub RebeccaPres., R&D, and CMOForm 4 sale2,676$658k0.6%RoutineSEC
Apr 8, 2024Apr 10, 2024Friedman Paul ADirectorForm 4 sale26,270$6.5M12.4%RoutineSEC
Apr 5, 2024Apr 5, 2024Taub RebeccaPres., R&D, and CMOForm 4 sale73,888$18M13.9%RoutineSEC
Apr 5, 2024Apr 5, 2024Friedman Paul ADirectorForm 4 sale73,730$18M28.4%RoutineSEC
Apr 3, 2024Apr 3, 2024Taub RebeccaOfficerForm 144 notice76,564$18.7MNoticeSEC
Apr 3, 2024Apr 3, 2024Friedman Paul ADirector, OfficerForm 144 notice100,000$24.4MNoticeSEC
Apr 2, 2024Apr 3, 2024Bate KennethDirectorForm 4 sale32,489$8.2M96.4%RoutineSEC
Apr 2, 2024Apr 3, 2024Daly James MDirectorForm 4 sale32,489$8.2M96.4%RoutineSEC
Apr 1, 2024Apr 3, 2024Levy Richard SDirectorForm 4 sale11,000$2.8M51.6%RoutineSEC
Apr 1, 2024Apr 1, 2024Daly James MDirectorForm 144 notice32,489$8.7MNoticeSEC
Apr 1, 2024Apr 1, 2024Bate KennethDirectorForm 144 notice32,489$8.7MNoticeSEC
Apr 1, 2024Apr 1, 2024Levy Richard SDirectorForm 144 notice11,000$2.9MNoticeSEC
Dec 15, 2023Dec 18, 2023Waltermire Robert E.Senior VP, Chief Pharma Dev.Form 4 sale4,000$942k41.4%UnusualSEC
Dec 13, 2023Dec 14, 2023Waltermire Robert E.Senior VP, Chief Pharma Dev.Form 4 sale3,800$847k40.1%UnusualSEC
Dec 5, 2023Dec 6, 2023Lynch Brian JosephSVP and General CounselForm 4 sale2,800$621k15.7%No planSEC
Nov 30, 2023Dec 1, 2023Lynch Brian JosephSVP and General CounselForm 4 sale7,000$1.4M31.8%UnusualSEC
Jul 12, 2023Jul 12, 2023Gollust Keith RDirectorForm 144 notice5,000$1.1MNoticeSEC
Jun 26, 2023Jun 26, 2023Gollust Keith RFormer AffiliateForm 144 notice11,477$2.7MNoticeSEC
Jun 26, 2023Jun 26, 2023Gollust Keith RFormer AffiliateForm 144 notice43,975$10.3MNoticeSEC
Mar 1, 2023Mar 2, 2023Waltermire Robert E.Senior VP, Chief Pharma Dev.Form 4 sale10,000$2.7M63.8%UnusualSEC
Jan 17, 2023Jan 19, 2023Levy Richard SDirectorForm 4 sale22,489$6.6M71.2%UnusualSEC
Jan 3, 2023Jan 6, 2023Lynch Brian JosephSVP and General CounselForm 4 sale13,000$3.7M100.0%UnusualSEC
Dec 23, 2022Dec 28, 2022Lynch Brian JosephSVP and General CounselForm 4 sale7,000$1.9M100.0%UnusualSEC
Dec 23, 2022Dec 28, 2022Sukhija RemyChief Commercial OfficerForm 4 sale30,000$8.2M100.0%UnusualSEC
Aug 19, 2020Aug 19, 2020Bay City Capital Management IV LLC10% ownerForm 4 sale30,000$3.3M41.2%UnusualSEC
Aug 19, 2020Aug 19, 2020Craves Fred BDirector, 10% ownerForm 4 sale30,000$3.3M41.2%UnusualSEC
Dec 13, 2019Dec 13, 2019Bay City Capital Fund IV Co Invesment Fund LP10% ownerForm 4 sale1.2M$127M93.2%UnusualSEC
Dec 13, 2019Dec 13, 2019Craves Fred BDirector, 10% ownerForm 4 sale1.2M$127M93.2%UnusualSEC
Nov 21, 2018Feb 26, 2020Milligan David VDirectorForm 4 sale20,000$2.3M100.0%UnusualSEC
Nov 19, 2018Feb 26, 2020Milligan David VDirectorForm 4 sale10,000$1.3M33.3%UnusualSEC
Jun 11, 2018Jun 13, 2018Schneebaum Marc RChief Financial OfficerForm 4 sale10,099$2.9M19.5%Plan not statedSEC
Jun 11, 2018Jun 12, 2018Craves Fred BDirector, 10% ownerForm 4 sale274,092$78.8M4.9%Plan not statedSEC
Jun 11, 2018Jun 12, 2018Friedman Paul AChief Executive OfficerForm 4 sale73,526$21.1M10.1%Plan not statedSEC
Jun 11, 2018Jun 12, 2018Bay City Capital LLCDirector, 10% ownerForm 4 sale280,000$80.5M71.2%UnusualSEC
Dec 14, 2015Dec 15, 2015Gollust Keith RDirectorForm 4 sale600,000$207k28.0%UnusualSEC
Dec 9, 2015Dec 9, 2015Gollust Keith RDirectorForm 4 sale745,892$286k25.9%UnusualSEC
Dec 8, 2015Dec 8, 2015Kovner BruceDirector, 10% ownerForm 4 sale1.5M$570k81.7%UnusualSEC
Dec 3, 2015Dec 3, 2015Kovner BruceDirector, 10% ownerForm 4 sale1.4M$610k61.6%UnusualSEC
Nov 30, 2015Nov 30, 2015Kovner BruceDirector, 10% ownerForm 4 sale3.1M$1.5M68.6%UnusualSEC
Nov 24, 2015Nov 24, 2015Kovner BruceDirector, 10% ownerForm 4 sale1.2M$516k31.7%UnusualSEC
Nov 20, 2015Nov 20, 2015Kovner BruceDirector, 10% ownerForm 4 sale1.5M$738k33.9%UnusualSEC
Nov 17, 2015Nov 19, 2015Gollust Keith RDirectorForm 4 sale100,000$41k3.4%Plan not statedSEC
Nov 17, 2015Nov 17, 2015Kovner BruceDirector, 10% ownerForm 4 sale1.2M$519k52.6%UnusualSEC
Nov 12, 2015Nov 12, 2015Kovner BruceDirector, 10% ownerForm 4 sale5.4M$3M70.0%UnusualSEC
Jun 18, 2012Jun 20, 2012Rieder Wendy EVP, IP and Legal, Gen. CounselForm 4 sale7,170$43k26.6%UnusualSEC
Jun 4, 2012Jun 6, 2012Rieder Wendy EVP, IP and Legal, Gen. CounselForm 4 sale7,170$39k26.6%UnusualSEC
Mar 1, 2012Mar 5, 2012Vukovic VojoSVP, Chief Medical OfficerForm 4 sale2,555$12k10.3%Plan not statedSEC
Mar 1, 2012Mar 5, 2012Koya KeizoSr. VP, Drug DevelopmentForm 4 sale6,844$32k34.5%UnusualSEC
Mar 1, 2012Mar 5, 2012Ehrlich Keith SVP, Fin. and Admin., CFOForm 4 sale4,397$21k20.0%Plan not statedSEC
Apr 25, 2011Apr 26, 2011Koya KeizoSr. VP, Drug DevelopmentForm 4 sale20,000$116k50.2%UnusualSEC
Mar 1, 2011Mar 3, 2011Vukovic VojoSVP, Chief Medical OfficerForm 4 sale2,617$14k14.9%Plan not statedSEC
Mar 1, 2011Mar 3, 2011Rieder Wendy EVP, IP and Legal, Gen. CounselForm 4 sale5,284$28k25.5%UnusualSEC
Mar 1, 2011Mar 3, 2011Ehrlich Keith SVP, Fin. and Admin., CFOForm 4 sale2,537$14k12.6%Plan not statedSEC
Mar 1, 2011Mar 3, 2011Koya KeizoSr. VP, Drug DevelopmentForm 4 sale18,270$96k35.6%UnusualSEC
Aug 5, 2010Aug 6, 2010Bailey Michael PSr. VP, Chief Comm. OfficerForm 4 sale4,000$13k11.9%Plan not statedSEC
Jan 5, 2009Jan 6, 2009Chadwick Jeremy GSr. VP, Pgm Mgmt and Clin OpsForm 4 sale4,573$28k22.4%Plan not statedSEC
Jan 5, 2009Jan 6, 2009Ehrlich Keith SVP, Fin. and Admin., CFOForm 4 sale5,600$35k27.4%UnusualSEC
Jan 5, 2009Jan 6, 2009Rieder Wendy EVP, IP and Legal, Gen. CounselForm 4 sale5,000$31k24.5%Plan not statedSEC